Syneos Health_rgb_r.jpg
INC Research/inVentiv Health Reports Third Quarter 2017 Results
09. November 2017 06:20 ET | INC Research, LLC
Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively.Combined Company adjusted net service revenue of $766.6...
Syneos Health_rgb_r.jpg
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
19. Oktober 2017 17:02 ET | INC Research, LLC
RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
Syneos Health_rgb_r.jpg
Investigative Sites Honor INC Research/inVentiv Health with 2017 Society for Clinical Research Sites Eagle Award
10. Oktober 2017 11:36 ET | INC Research, LLC
RALEIGH, N.C., Oct. 10, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
Syneos Health_rgb_r.jpg
INC Research/inVentiv Health to Present at Upcoming September Conferences
21. August 2017 17:01 ET | INC Research, LLC
RALEIGH, N.C., Aug. 21, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization, today announced that Chief Financial...
Syneos Health_rgb_r.jpg
INC Research and inVentiv Health Announce Successful Completion of Merger
01. August 2017 09:12 ET | INC Research, LLC
Combination Creates the Only Fully Integrated Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3 Billion Relaunch Under New Brand Planned for 2018 RALEIGH, N.C. and...
Syneos Health_rgb_r.jpg
INC Research Reports Second Quarter 2017 Results
27. Juli 2017 06:10 ET | INC Research, LLC
Highlights Book-to-bill ratio of 1.6x, 1.5x, and 1.4x for the three-, six-, and twelve-month periods ended June 30, 2017, respectively.Net new business awards of $423.8 million and $783.8 million for...
Syneos Health_rgb_r.jpg
INC Research Further Expands Catalyst Program with Launch of Psychiatry Catalyst Site Network
05. Juli 2017 10:30 ET | INC Research, LLC
RALEIGH, N.C., July 05, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the launch of the...
Syneos Health_rgb_r.jpg
INC Research Grows Presence in Japan with Office Expansion and Relocation
28. Juni 2017 20:10 ET | INC Research, LLC
RALEIGH, N.C., June 28, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization (CRO), today announced the expansion and...
Syneos Health_rgb_r.jpg
INC Research to Lead the Conversation on ICH E6 R2 Preparedness at DIA 2017 Annual Meeting
14. Juni 2017 16:51 ET | INC Research, LLC
RALEIGH, N.C., June 14, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced an extensive presence at...
Syneos Health_rgb_r.jpg
INC Research Schedules First Quarter 2017 Earnings Call for Wednesday, May 10, 2017
20. April 2017 17:25 ET | INC Research, LLC
RALEIGH, N.C., April 20, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its first quarter 2017...